Shengyan Hong

1.7k total citations
20 papers, 926 citations indexed

About

Shengyan Hong is a scholar working on Statistics and Probability, Oncology and Molecular Biology. According to data from OpenAlex, Shengyan Hong has authored 20 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Statistics and Probability, 8 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Shengyan Hong's work include Statistical Methods and Inference (6 papers), Advanced Statistical Methods and Models (4 papers) and Statistical Methods in Clinical Trials (4 papers). Shengyan Hong is often cited by papers focused on Statistical Methods and Inference (6 papers), Advanced Statistical Methods and Models (4 papers) and Statistical Methods in Clinical Trials (4 papers). Shengyan Hong collaborates with scholars based in United States, China and Germany. Shengyan Hong's co-authors include Marc C. Chamberlain, Astra M. Liepa, Michael Weller, Lawrence Cher, Donald Thornton, Wolfgang Wick, Alain Carpentier, Luna Musib, Martin J. van den Bent and Howard A. Fine and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Shengyan Hong

19 papers receiving 896 citations

Peers

Shengyan Hong
Rifaquat Rahman United States
Akihiro Hirakawa Japan
Meghna Samant United States
Vincenzo Di Nunno Italy
Mizue Krygowski United States
Maria Martinez‐García Spain
Robert Penny United States
Qinhua Ru United States
Paolo Fina Italy
Vanda M. Stepanek United States
Rifaquat Rahman United States
Shengyan Hong
Citations per year, relative to Shengyan Hong Shengyan Hong (= 1×) peers Rifaquat Rahman

Countries citing papers authored by Shengyan Hong

Since Specialization
Citations

This map shows the geographic impact of Shengyan Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyan Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyan Hong more than expected).

Fields of papers citing papers by Shengyan Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyan Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyan Hong. The network helps show where Shengyan Hong may publish in the future.

Co-authorship network of co-authors of Shengyan Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Shengyan Hong. A scholar is included among the top collaborators of Shengyan Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengyan Hong. Shengyan Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Phuphanich, Surasak, Jeffrey J. Raizer, Marc C. Chamberlain, et al.. (2016). Phase II study of MEDI-575, an anti-platelet-derived growth factor-α antibody, in patients with recurrent glioblastoma. Journal of Neuro-Oncology. 131(1). 185–191. 18 indexed citations
3.
Becerra, Carlos, Paul Conkling, Nicholas J. Vogelzang, et al.. (2014). A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 74(5). 917–925. 9 indexed citations
4.
Hong, Shengyan, et al.. (2012). Predictive power to assist phase 3 go/no go decision based on phase 2 data on a different endpoint. Statistics in Medicine. 31(9). 831–843. 16 indexed citations
5.
Wick, Wolfgang, Vinay K. Puduvalli, Marc C. Chamberlain, et al.. (2010). Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma. Journal of Clinical Oncology. 28(7). 1168–1174. 359 indexed citations
6.
7.
Hong, Shengyan, et al.. (2009). Evaluation of the sensitivity and specificity of qualitative diagnostic test under normal assumption. Model Assisted Statistics and Applications. 4(2). 123–130. 1 indexed citations
8.
Socinski, Mark A., Egbert F. Smit, Paul Lorigan, et al.. (2009). Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer. Journal of Clinical Oncology. 27(28). 4787–4792. 159 indexed citations
9.
Jiang, Honghua, James T. Symanowski, Sofia Paul, et al.. (2008). The type I error and power of non‐parametric logrank and Wilcoxon tests with adjustment for covariates—A simulation study. Statistics in Medicine. 27(28). 5850–5860. 17 indexed citations
10.
Jassem, Jacek, Rodryg Ramlau, Armando Santoro, et al.. (2008). Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma. Journal of Clinical Oncology. 26(10). 1698–1704. 178 indexed citations
11.
Hong, Shengyan & Yanping Wang. (2007). A three‐outcome design for randomized comparative phase II clinical trials. Statistics in Medicine. 26(19). 3525–3534. 12 indexed citations
12.
Rowinsky, Eric K., Muralidhar Beeram, Lisa A. Hammond, et al.. (2007). A Phase I and Pharmacokinetic Study of Pemetrexed Plus Irinotecan in Patients with Advanced Solid Malignancies. Clinical Cancer Research. 13(2). 532–539. 9 indexed citations
13.
Höchster, Howard S., E. Kettner, H. Kröning, et al.. (2005). Phase I/II Dose-Escalation Study of Pemetrexed plus Irinotecan in Patients with Advanced Colorectal Cancer. Clinical Colorectal Cancer. 5(4). 257–262. 12 indexed citations
14.
Hong, Shengyan. (2003). Bahadur representation and its applications for local polynomial estimates in nonparametric M -regression. Journal of nonparametric statistics. 15(2). 237–251. 14 indexed citations
15.
Hong, Shengyan. (2002). Normal Approximation Rate and Bias Reduction for Data-Driven Kernel Smoothing Estimator in a Semiparametric Regression Model. Journal of Multivariate Analysis. 80(1). 1–20. 12 indexed citations
16.
Hong, Shengyan, et al.. (1999). Normal Approximation Rate of the Kernel Smoothing Estimator in a Partial Linear Model. Journal of Multivariate Analysis. 70(2). 207–220. 1 indexed citations
17.
Hong, Shengyan. (1999). AUTOMATIC BANDWIDTH CHOICE IN A SEMIPARAMETRIC REGRESSION MODEL. 10 indexed citations
18.
Gao, Jiti, et al.. (1996). BERRY-ESSEEN BOUNDS OF ERROR VARIANCE ESTIMATION IN PARTLY LINEAR MODELS. Chinese Annals of Mathematics Series B. 17(4). 477–490. 5 indexed citations
19.
Hong, Shengyan. (1993). A law of the iterated logarithm forL 1-norm kernel estimator of the conditional median. Acta Mathematicae Applicatae Sinica English Series. 9(3). 256–268. 3 indexed citations
20.
Hong, Shengyan. (1992). LOCAL OSCILLATION MODULUS OF THE UNIFORM EMPIRICAL PROCESS. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rifaquat Rahman Breakdown of academic impact, for papers by Akihiro Hirakawa Breakdown of academic impact, for papers by Meghna Samant Breakdown of academic impact, for papers by Vincenzo Di Nunno Breakdown of academic impact, for papers by Mizue Krygowski Breakdown of academic impact, for papers by Maria Martinez‐García Breakdown of academic impact, for papers by Robert Penny Breakdown of academic impact, for papers by Qinhua Ru Breakdown of academic impact, for papers by Paolo Fina Breakdown of academic impact, for papers by Vanda M. Stepanek
Rankless by CCL
2026